NCT04598152

Brief Summary

The primary purpose of this research is to gather scientific information about how different people's brains work when they look at different types of pictures. This will help to improve the investigators' understanding of the way the brain works for people who are depressed or anxious, and this knowledge could help lead to better diagnosis and treatment.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2018

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2018

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 9, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 9, 2020

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

October 10, 2020

Completed
12 days until next milestone

First Posted

Study publicly available on registry

October 22, 2020

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

January 4, 2022

Completed
Last Updated

January 4, 2022

Status Verified

December 1, 2021

Enrollment Period

1.4 years

First QC Date

October 10, 2020

Results QC Date

August 30, 2021

Last Update Submit

December 5, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Blood Oxygen Level Dependent (BOLD) Response in the Precuneus During an Emotion Regulation Task Completed During fMRI Scanning.

    The investigators will determine the effects of TDCS on BOLD response in the precuneus/posterior cingulate gyrus. The BOLD signal is a measure of regional blood flow in the brain and is used as a proxy for neural activity in specific brain regions. Values below represent pre-post change in BOLD response to the emotion regulation task that participants complete during fMRI scanning. We hypothesize that tDCS applied to the target used in this study will decrease BOLD signal (lower values) during critical components of this task, normalizing function in this region.

    1 week (between baseline and repeat scanning)

Secondary Outcomes (1)

  • The Percentage of Patients Who Reported a Side Effect in the Active tDCS Condition But Not the Sham tDCS Condition

    30 minutes to 1 hour (the period during which the tDCS device was worn) on each of two scan days

Study Arms (1)

Transcranial Direct Current Stimulation during fMRI

EXPERIMENTAL

Each subject will undergo transcranial direct current stimulation twice while completing a task in the functional magnetic resonance imaging scanner.

Device: TDCS - transcranial direct current stimulation

Interventions

TDCS involves passing a weak current through the brain. One variant, cathodal TDCS, can be used to temporarily hyperpolarize cortical pyramidal cells, thereby decreasing neuronal connections. TDCS has been explored as a possible treatment for depression, but results to date are mixed. No work has examined whether TDCS can be used in an individually guided manner to target locations in the parietal cortex and alter the patterns of circuitry dysfunction described previously.

Transcranial Direct Current Stimulation during fMRI

Eligibility Criteria

Age18 Years - 30 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Between 18-30years old
  • Score \> 10 on the QIDS or \> 60 on the PROMIS-A
  • We will use a flexible extreme groups recruitment strategy to ensure an adequate distribution of ESC scores. We will ensure that at least 62% of the sample will be composed of those scoring .5 SD above or below the mean, as measured by the NEO-PI-R. This value corresponds to the expected values assuming a normal distribution of the trait.
  • Normal or corrected to normal vision with contact lenses
  • Able to provide informed consent in English
  • Right-handed (Annett criteria)

You may not qualify if:

  • Have a history of head trauma with loss of consciousness.
  • Have a systemic medical illness that may impact fMRI measures of cerebral blood flow.
  • Are pregnant (self report and tested for as part of any scan by the scanning center and not this protocol)
  • Not native English speaking or not fluent
  • Premorbid NAART IQ estimate\<85;
  • Visual disturbance (worse than 20/40 Snellen visual acuity) that is not corrected
  • If have visual disturbance, only access to correction with glasses (i.e., no access to contact lenses).
  • Left/mixed handedness (Annett criteria), to ensure a uniform hemispheric dominance for interpretation of neuroimaging data
  • Active suicidal ideation in need of immediate treatment
  • Scoring below the cutoffs on both the QIDS and the PROMIS-A
  • History of alcohol/substance use disorder (including nicotine) and/or illicit substance use (except cannabis) over the last 3 months, determined by the MINI. Lifetime/present cannabis use (non-disordered levels) will be allowed, given its common usage in individuals in this age range.
  • Current or past psychotic-spectrum disorder
  • History of seizures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Pittsburgh

Pittsburgh, Pennsylvania, 15213, United States

Location

MeSH Terms

Conditions

DepressionAnxiety Disorders

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorMental Disorders

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Limitations and Caveats

This study was closed due to Covid 19 restrictions. Only 3 people completed the protocol. No conclusions should be drawn from the results reported. Because of the low sample size, no statistical analyses were undertaken.

Results Point of Contact

Title
Jay Fournier, PhD
Organization
The Ohio State University College of Medicine

Study Officials

  • Jay C Fournier, Ph. D.

    University of Pittsburgh

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: The first part of the study consists of screening procedures that are meant to determine if potential participants are eligible to take part in the remainder of the study. If you qualify to take part in the scanning portion of the study, you will have 2 scanning sessions on separate days approximately a week apart. For each scan session you will undergo a functional Magnetic Resonance Imaging (fMRI) scan that lasts approximately 30 minutes and no more than 1 hour. The total time you will spend for each scan session will be between 1-3 hours. During the scanning session you will receive transcranial direct current stimulation (tDCS). Prior to scanning, sponge-electrodes will be placed on your scalp. These electrodes will be connected to a stimulator. This stimulator will apply weak currents to the brain while the MRI takes pictures of your brain's responses. The stimulation current that you will experience is usually less than a 6-volt battery but may be increased up to 15-volts.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Assistant Professor of Psychiatry

Study Record Dates

First Submitted

October 10, 2020

First Posted

October 22, 2020

Study Start

October 1, 2018

Primary Completion

March 9, 2020

Study Completion

March 9, 2020

Last Updated

January 4, 2022

Results First Posted

January 4, 2022

Record last verified: 2021-12

Locations